Aerovate Therapeutics, Inc.
AVTE
$2.66
$0.083.10%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 78.62M | 88.73M | 104.20M | 99.33M | 122.44M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 649.00K | 993.00K | 6.11M | 3.60M | 1.54M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 845.00K | 882.00K | 452.00K | 304.00K | 250.00K |
| Total Current Assets | 80.12M | 90.61M | 110.76M | 103.24M | 124.23M |
|
|
|||||
| Total Current Assets | 80.12M | 90.61M | 110.76M | 103.24M | 124.23M |
| Net Property, Plant & Equipment | 215.00K | 273.00K | 853.00K | 985.00K | 902.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 81.00K | 81.00K | 2.60M | 2.28M |
| Total Assets | 80.33M | 90.96M | 111.69M | 106.82M | 127.42M |
|
|
|||||
| Total Accounts Payable | 224.00K | 908.00K | 4.18M | 3.31M | 2.40M |
| Total Accrued Expenses | 2.87M | 8.66M | 11.70M | 11.09M | 13.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 417.00K | 459.00K | 475.00K | 445.00K | 420.00K |
| Total Finance Division Other Current Liabilities | 319.00K | 292.00K | 669.00K | 674.00K | 1.09M |
| Total Other Current Liabilities | 319.00K | 292.00K | 669.00K | 674.00K | 1.09M |
| Total Current Liabilities | 3.83M | 10.32M | 17.02M | 15.52M | 17.64M |
|
|
|||||
| Total Current Liabilities | 3.83M | 10.32M | 17.02M | 15.52M | 17.64M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 81.00K | 206.00K | 329.00K | 255.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 70.00K | 70.00K | 70.00K | 70.00K | 70.00K |
| Total Liabilities | 3.90M | 10.47M | 17.30M | 15.92M | 17.96M |
|
|
|||||
| Common Stock & APIC | 309.38M | 307.89M | 305.87M | 277.55M | 272.64M |
| Retained Earnings | -233.05M | -227.62M | -211.39M | -186.61M | -163.42M |
| Treasury Stock & Other | 105.00K | 224.00K | -83.00K | -33.00K | 237.00K |
| Total Common Equity | 76.43M | 80.49M | 94.40M | 90.90M | 109.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 76.43M | 80.49M | 94.40M | 90.90M | 109.46M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 76.43M | 80.49M | 94.40M | 90.90M | 109.46M |
|
|
|||||
